-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains In-Line on Moderna, Lowers Price Target to $32

Benzinga·05/02/2025 13:22:40
Listen to the news
Evercore ISI Group analyst Cory Kasimov maintains Moderna (NASDAQ:MRNA) with a In-Line and lowers the price target from $50 to $32.